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Abstract
COVID-19 has affected the world tremendously. It is critical that biological exper-
iments and clinical designs are informed by computational approaches for time- and
cost-effective solutions. Comparative analyses particularly can play a key role to re-
veal structural changes in proteins due to mutations, which can lead to behavioural
changes, such as the increased binding of the SARS-CoV-2 surface glycoprotein to
human ACE2 receptors. The aim of this report is to provide an easy to follow tuto-
rial for biologists and others without delving into different bioinformatics tools. More
complex analyses such as the use of large-scale computational methods can then be
utilised. Starting with a SARS-CoV-2 genome sequence, the report shows visualising
DNA sequence features, deriving amino acid sequences, and aligning different genomes
to analyse mutations and differences. The report provides further insights into how the
SARS-CoV-2 surface glycoprotein mutated for higher binding affinity to human ACE2
receptors, compared to the SARS-CoV protein, by integrating existing 3D protein
models.
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Introduction
Severe acute respiratory syndrome (SARS)-related coronaviruses have previously caused two
pandemics.1 The recent SARS Coronavirus 2 (SARS2-CoV-2) outbreak has had unprece-
dented effects so far. It is essential to develop data integration mechanisms in order to gain
insights using data that already exists. For example, genome-wide comparisons can be used
to inform subsequent computational analyses which can potentially be used to search for
drugs and to develop computational models.
Taxonomy classifications offer a systematic approach to link data from different organ-
isms. The taxonomy id for SARS-CoV-2 is reported as 2697049 by the National Center
for Biotechnology (NCBI) taxonomy browser2 which also lists synonyms that can be used
when searching for information in different databases (https://www.ncbi.nlm.nih.gov/
Taxonomy/Browser/wwwtax.cgi?id=2697049). Moreover, the taxonomy id 694009 is used
to group all SARS-related coronavirus taxonomies. This list can especially be useful to
search for related sequences in order to infer information via comparative genomics ap-
proaches. For example, the NCBI Virus3 database can be queried with these taxonomy ids
to retrieve SARS-CoV-2 related nucleotide and protein sequences.
The SARS-CoV-2 genome sequences can also be accessed directly from the NCBI’s Gen-
Bank database (https://www.ncbi.nlm.nih.gov/genbank/sars-cov-2-seqs). Related
information includes where a virus was isolated from. Some of these GenBank files include
only sequences and some of them provide annotations about genome locations of important
sequence features.
This tutorial initially uses two genome sequences: one for SARS-CoV-2 and another one
for SARS-CoV. Regarding the former, the GenBank entry LC528232 was selected. LC528232
was created for a strain which was isolated in Japan. Regarding the latter, the GenBank
entry AP006557, which was deposited in 2006, was selected.
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Genomic features
The GenBank files include annotations about sequence features, which can be visualised
and analysed using various tools. In this report, the analyses were carried out using CLC
Genomics Workbench 20.0.3. GenBank files were initially imported into this tool which
was then used to analyse the annotated sequence features in more detail. For example, the
surface glycoprotein denoted as ‘S’ is shown in Figure 1.
Figure 1: SARS-CoV-2 sequence features that are captured in GenBank files are shown.
In order understand the mutations in the surface glycoprotein, a new entry for the related
coding sequence (CDS) was created in CLC Genomics Workbench. The corresponding CDS
feature was selected and the nucleotides were copied to create this new entry. CLC Genomics
Workbench was then used to display restriction sites and protein translation information
(Figure 2).
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Figure 2: Restriction sites in the surface glycoprotein CDS, labelled as ‘S’.
Predicting secondary structures
Understanding secondary structure formations and where mutations occur can provide in-
sights into the effects of these mutations in the SARS-CoV-2 surface glycoprotein CDS.
Hence, a new entry for the corresponding amino acid sequences was created in CLC Genomics
Workbench by using the ‘Toolbox - Classical Sequence Analysis - Nucleotide
Analysis - Translate to Protein’ option. Alpha-helix and beta-strand formations were
predicted using the ‘Toolbox - Classical Sequence Analysis - Protein Analysis -
Predict Secondary Structure’ option. The inferred information was then incorporated
as annotations into the entry for the amino acid sequences (Figure 3).
Figure 3: The surface glycoprotein secondary structure predictions. Red arrows represent
beta-strands and blue arrows represent alpha-helices.
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Sequence alignment
It is reported that the SARS-CoV-2 surface glycoprotein is optimised to bind to human ACE2
receptors.4 In order to analyse the effects of these mutations further, the protein sequence
can be aligned to previously known similar sequences. Figure 4 shows the alignment of
the surface glycoprotein amino acid sequences from SARS-CoV-2 (LC528232) and SARS-
CoV (AP006557). Although the alignment shows high similarities between the amino acid
sequences, gaps and mutations also exist.
Figure 4: Aligned surface glycoprotein amino acid sequences from SARS-CoV-2 (LC528232)
and SARS-CoV (AP006557).
A more detailed view of the alignment of the two protein sequences can be seen in Figure
5. Secondary structures are integrated into the view. The surface exposed regions are
compared using different options such as the Kyte-Doolittle scale. Additional options can
be configured from the ‘Alignment Settings - Protein info’ tab.
Figure 5: Aligned surface glycoprotein amino acid sequences from SARS-CoV-2 (LC528232)
and SARS-CoV (AP006557). Red blocks at the top represent beta-strands and blue blocks
represent alpha-helices.
Wan and co-workers reported that mutations in the surface glycoprotein’s five amino acids
can play a critical role in binding to the human ACE2 receptors.5 Anderson and co-workers
provide their own insights, including another 6th critical amino acid. Here, we integrated
secondary structure predictions and realigned the sequences in order to show how these five
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mutations may affect the binding of the SARS-CoV-2 protein (Figure 6). The alignment of
secondary structure predictions show the additions of three beta strands and the loss of one
beta strand. These changes may affect the folding of the protein and hence its binding.
Figure 6: Five key mutations are shown using the blue boxes. These mutations are reported
to change the binding affinity of the surface glycoprotein to the human ACE2 receptors.
Comparisons are displayed for SARS-CoV-2 (LC528232) and SARS-CoV (AP006557).
Predictions for secondary structures may reveal some information about the binding of
the surface glycoprotein. However, 3D models may help understanding the surfaces that are
exposed and are likely to bind to other molecules. In order to understand the effects of the
mutated region in Figure 6 (shown using the dashed box), an existing 3D model of the SARS-
CoV protein was searched for. CLC Genomics Workbench’s the ‘Toolbox - Classical
Sequence Analysis - Protein Analysis - Find and Model Structure’ option was used
to search for existing 3D models. The first ranked entry with the most ‘Match identity’ and
‘Coverage’ was selected. The Protein Data Bank (PDB)6 identifier of this entry is ‘5X58
Prefusion Structure of SARS-CoV Spike Glycoprotein , Conformation 1’.7 Using the CLC
Genomics Workbench’s ‘Project Settings - Sequence tools - Show Sequence’ option,
the 5X58’s ‘Chain C’ sequence was first displayed and it was then aligned to the SARS-CoV
protein sequence (AP006557) using the ‘Align to Existing Sequence’ option. The first
picture on the left in Figure 7 shows the structure of the chain. The SARS-CoV amino acid
sequences from the area with the key mutations (shown using the dashed box in Figure 6)
were highlighted using the sequence editor. The second picture on the right in Figure 7
shows the corresponding amino acid areas highlighted in the 3D structural view.
A similar analysis was also carried out for the SARS-CoV-2 Chain C. The ‘6W41’ entry,8
including the details about the crystal structure of the SARS-CoV-2 receptor binding domain,
was downloaded from the Protein Data Bank. A collection of related-entries can be found
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Figure 7: The binding region in SARS-CoV. The left picture shows the SARS-CoV Chain C,
which binds to the human ACE2 receptors. The right picture shows the area corresponding
to the highlighted sequence below, which represent the mutation area shown using the dashed
box in Figure 6.
at the European Bioinformatics Institute’s COVID-19 page.9 The sequence from the ‘6W41’
model was then aligned to the SARS-CoV-2 sequence (LC528232). Compared to the SARS-
CoV secondary structures, both the CLC Genomics Workbench predictions and the SARS-
CoV-2 ‘6W41’ model reveal additional beta strands in the mutated region (shown using the
dashed box in Figure 6) of the surface glycoprotein. The 3D view of the binding region is
shown in Figure 8. The second picture on the right in Figure 8 shows the corresponding
amino acid areas highlighted in the 3D structural view.
CLC Genomic Workbench was then used to align the two SARS-CoV-2 and SARS-
CoV 3D structures using the ‘Project Settings - Structure tools - Align Protein
Structure’ option. Figure 9 shows the alignment using red and blue colours for SARS-
CoV-2 and SARS-CoV respectively. The third picture on the right shows the region that
aligns with the ACE2 receptors during binding.10 The middle picture shows the four key
amino acid sequences that mutated in SARS-CoV-2. These key mutations affect the binding
affinity.10
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Figure 8: The binding region in SARS-CoV-2. The sequences from 6W41 and LC528232
were aligned. The left picture shows the SARS-CoV-2 Chain C, which binds to the human
ACE2 receptors. The right picture shows the area corresponding to the highlighted sequence
below, which represents the mutation area shown using the dashed box in Figure 6.
Figure 9: SARS-CoV-2 (in red colour) and SARS-CoV (in blue colour) 3D models of the
binding regions to ACE2 sites are aligned. The middle picture shows the locations of the
four key mutations in SARS-CoV-2. The third picture on the right shows the ACE2 binding
area. SARS-CoV-2 sequences are shown at the bottom and the highlighted sequences are
displayed using blue boxes.
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Discussion
In this report, insights from the sequence analysis of SARS-CoV-2 were presented. Genome-
wide comparisons between SARS-CoV-2 and SARS-CoV further shed lights into understand-
ing the potential effects of key mutations in the surface glycoprotein amino acid sequences.
Our analysis is inline with the current reports.10,11 Although, some of the mutations may play
an important role in binding to the human ACE2 receptors, there are several mutations that
may have strengthened the binding affinity of the surface glycoprotein. Both the predictions
and the 3D models reveal additional beta strands and hydrogen bonds. These additional
mutations may cause changes in structural conformations and cause a higher binding affinity.
This report has been prepared in a tutorial style using CLC Genomics Workbench. The
approach can be adopted by biologists and others to have initial understanding of SARS-
CoV-2 mutations, and their relationships to SARS-CoV and other closely related viruses.
Initial findings can then be explored further by using other specialised tools and approaches.
Computational methods are especially promising. Machine learning, artificial intelli-
gence, data integration and mining, visualisation, computational and mathematical mod-
elling for key biochemical interactions and disease control mechanisms can usefully be applied
to provide solutions in a cost- and time- effective manner. We hope that this report is useful
to those who wish to understand essential information about SARS-CoV-2 for subsequent
analyses.
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